Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P F Ambros

Showing results (61-70 of 89) with videos related to

Pageof 9
Sort By:
International Journal of Cancer|March 12, 1998
Predictive potential of testing for bone marrow involvement in Ewing tumor patients by RT-PCR: a preliminary evaluationA Zoubek, R Ladenstein, R Windhager, et al.
Klinische Padiatrie|July 1, 1994
[The EWS gene rearrangement in Ewing tumors: key to the disease]H Kovar, A Zoubek, C Pfleiderer, et al.
Blood|January 15, 1994
Flow cytometric assessment of human MIC2 expression in bone marrow, thymus, and peripheral bloodM N Dworzak, G Fritsch, P Buchinger, et al.
British Journal of Cancer|November 1, 1994
Variability of EWS chimaeric transcripts in Ewing tumours: a comparison of clinical and molecular dataA Zoubek, C Pfleiderer, M Salzer-Kuntschik, et al.
Cancer Genetics and Cytogenetics|April 1, 1996
Metastatic extraosseous Ewing tumor. Association of the additional translocation der(16)t(1;16) with the variant EWS/ERG rearrangement in a case of cytogenetically inconspicuous chromosome 22B Stark, A Zoubek, C Hattinger, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
First experience with prognostic factors in unselected neuroblastoma patients. The Austrian Neuroblastoma 87 StudyR Ladenstein, C Urban, H Gadner, et al.
Klinische Padiatrie|July 1, 1995
[Minimal metastatic and minimal residual disease in patients with Ewing tumors]A Zoubek, C Pfleiderer, P F Ambros, et al.
Medical and Pediatric Oncology|December 7, 2000
Combined (111)In-pentetreotide scintigraphy and (123)I-mIBG scintigraphy in neuroblastoma provides prognostic informationF H Schilling, H Bihl, H Jacobsson, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Regression and progression in neuroblastoma. Does genetics predict tumour behaviour?P F Ambros, I M Ambros, S Strehl, et al.
Oncogene|February 2, 1995
Mutational hot spots within the carboxy terminal region of the LMP1 oncogene of Epstein-Barr virus are frequent in lymphoproliferative disordersH Knecht, E Bachmann, P Brousset, et al.
Pageof 9

Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
International Journal of Cancer|March 12, 1998
Predictive potential of testing for bone marrow involvement in Ewing tumor patients by RT-PCR: a preliminary evaluationA Zoubek, R Ladenstein, R Windhager, et al.
Klinische Padiatrie|July 1, 1994
[The EWS gene rearrangement in Ewing tumors: key to the disease]H Kovar, A Zoubek, C Pfleiderer, et al.
Blood|January 15, 1994
Flow cytometric assessment of human MIC2 expression in bone marrow, thymus, and peripheral bloodM N Dworzak, G Fritsch, P Buchinger, et al.
British Journal of Cancer|November 1, 1994
Variability of EWS chimaeric transcripts in Ewing tumours: a comparison of clinical and molecular dataA Zoubek, C Pfleiderer, M Salzer-Kuntschik, et al.
Cancer Genetics and Cytogenetics|April 1, 1996
Metastatic extraosseous Ewing tumor. Association of the additional translocation der(16)t(1;16) with the variant EWS/ERG rearrangement in a case of cytogenetically inconspicuous chromosome 22B Stark, A Zoubek, C Hattinger, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
First experience with prognostic factors in unselected neuroblastoma patients. The Austrian Neuroblastoma 87 StudyR Ladenstein, C Urban, H Gadner, et al.
Klinische Padiatrie|July 1, 1995
[Minimal metastatic and minimal residual disease in patients with Ewing tumors]A Zoubek, C Pfleiderer, P F Ambros, et al.
Medical and Pediatric Oncology|December 7, 2000
Combined (111)In-pentetreotide scintigraphy and (123)I-mIBG scintigraphy in neuroblastoma provides prognostic informationF H Schilling, H Bihl, H Jacobsson, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Regression and progression in neuroblastoma. Does genetics predict tumour behaviour?P F Ambros, I M Ambros, S Strehl, et al.
Oncogene|February 2, 1995
Mutational hot spots within the carboxy terminal region of the LMP1 oncogene of Epstein-Barr virus are frequent in lymphoproliferative disordersH Knecht, E Bachmann, P Brousset, et al.
Pageof 9